Prime Movers Lab — 2021 Investments
7 investments dated 2021 · listed companies and verified rows first · show all
Pasadena, US
Adrian Corless(Executive Officer, Director)Lindsy Sanders(Director)Tom McGovern(Director)
BoardBrandon Simmons(Director)Carly Anderson(Director)
Board seatBill Gross· per SEC Form D · $35M raise · filed Oct 2021
Co-investorsBay Bridge Ventures Climate
Windsor, US
James P. Linton(Executive Officer, Director)Marc-Francois Pelletier(Executive Officer, Director)Paul Predki(Executive Officer, Director)Stephanie Ann George(Executive Officer)
BoardChris Camarsh(Director)
Board seatAmy Kruse· per SEC Form D · $6M raise · filed Nov 2021
Co-investorsLifeSci Venture Partners
Elevian is a biotechnology company developing rGDF11, a recombinant protein therapy shown in preclinical animal models to promote recovery of motor function after ischemic and hemorrhagic stroke by stimulating new blood vessel formation, neurogenesis, and reducing inflammation.
BiotechHealthtechLongevityMenlo Park, US
Mark Allen(Executive Officer, Director)Casey J McGlynn(Executive Officer)Sebastian Giwa(Executive Officer, Director)Luis Alvarez(Executive Officer)Daniel Marshak(Director)
BoardSuzanne Fletcher(Director)
Board seatCaleb Bell III· per SEC Form D
Co-investorsBold Capital PartnersThynk CapitalBOLD CapitalFor Good VenturesLauder PartnersWTI
Focused Energy commercializes fusion ignition technology to develop the first commercial laser fusion power plant.
Deep TechEnergyHardwareBiblis, DE
Board seatJon Layman· per SEC Form D
Co-investorsA-Rod CorpNucleation Capital
Brooklyn, US
Marc Collins(Executive Officer, Director)Itai Madamombe(Executive Officer, Director)
Board seatGaetano Crupi· per SEC Form D · $2.1M raise · filed Jul 2021
Synthetic peptide vaccines for chronic diseases.
Dallas, US
Board seatDakin Sloss· per SEC Form D
Co-investorsMBX Capital
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Co-investorsAcequia Capital (AceCap)BlueYard CapitalGlobal BrainHAWKTAILIaso VenturesRaptor Group+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.